Iranian Society of Gynecology Oncology

Document Type : Case Report Article

Authors

1 Department of Obstetrics and Gynecology, Haji Medan General Hospital, North Sumatera, Indonesia

2 Department of Obstetrics and Gynecology, Adam Malik General Hospital, North Sumatera, Indonesia

3 Department of Anatomical Pathology, Haji Medan General Hospital, North Sumatera, Indonesia

Abstract

Endometrial cancer is the 6th most common cancer in women worldwide. Rarely does occur in the postpartum period. Fifteen cases of endometrial cancer in the postpartum period have been reported before, but the diagnosis of endometrial carcinoma as a cause of secondary postpartum hemorrhage is hardly predicted. A 37-year-old, Para 4, presented two weeks after a cesarean section and had recurrent vaginal bleeding. The patient was treated conservatively. While being observed, vaginal bleeding still occurred with more volume. We decided to perform a total abdominal hysterectomy. Histopathology confirmed a low-grade endometrioid carcinoma of the corpus uteri. Endometrial cancer might cause a secondary postpartum hemorrhage, with the hypothesis that the depth of tumor invasion into the uterine muscle causes a distorted tissue architecture and the formation of new blood vessels that easily disrupt. The most common type of endometrial cancer in a postpartum woman is low grade with a favorable prognosis.

Keywords

Main Subjects

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [DOI:10.3322/caac.21492] [PMID]
2. Laing-Aiken Z, Ooi S, Mylvaganam G, Xie H, Ludlow J, Pather S. Grade 3 endometrioid adenocarinoma of the lower uterine segment diagnosed 6 weeks after a term delivery: A case report and literature review. Gynecol Oncol Rep. 2021;38:100884. [DOI:10.1016/j.gore.2021.100884] [PMID] [PMCID]
3. Shiomi M, Matsuzaki S, Kobayashi E, Hara T, Nakagawa S, Takiuchi T, et al. Endometrial carcinoma in a gravid uterus: a case report and literature review. BMC Pregnancy Childbirth. 2019;19(1):425. [DOI:10.1186/s12884-019-2489-y] [PMID] [PMCID]
4. Leunen K, Amant F, Debiec-Rychter M, Croes R, Hagemeijer A, Schoenmakers EFPM, Vergote I. Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation. Gynecol Oncol. 2003;91(1):265-71. [DOI:10.1016/S0090-8258(03)00477-3] [PMID]
5. Talayeh M, Arab M, Noei Teymoordash S, Afsharmoghadam N, Raoufi M, Ghavami B, Asghari M. Low-Grade Endometrial Stromal Sarcoma in a Young Woman: A Case Report. J Obstet Gynecol Cancer Res. 2022;7(6):569-73. [DOI:10.30699/jogcr.7.6.569]
6. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22(6):999-1012. [DOI:10.1016/j.bpobgyn.2008.08.004] [PMID]
7. King PA, Duthie SJ, Ven D, Dong ZG, Ma HK. Secondary Postpartum Haemorrhage. Aust N Z J Obstet Gynaecol. 1989;29(4):394-8. [DOI:10.1111/j.1479-828X.1989.tb01776.x] [PMID]
8. Goh C, Mathur M, Lim-Tan SK, Lim YK. Endometrial Hyperplasia as a Cause of Secondary Postpartum Hemorrhage in a Post Caesarean Section Patient. J Med Cases. 2018;9(6):183-6. [DOI:10.14740/jmc3064w]
9. Yang S, Thiel KW, Leslie KK. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol Metab. 2011;22(4):145-52. [DOI:10.1016/j.tem.2011.01.005] [PMID] [PMCID]
10. Yokoyama Y, Suzuki M, Sato Y, Iwagaki S, Takahashi Y, Iwata H. A Case of Undifferentiated Carcinoma in a 2-Month Postpartum Reproductive Tract with a Rapid and Fulminant Course. Case Rep Obstet Gynecol. 2021;2021:3516646. [DOI:10.1155/2021/3516646] [PMID] [PMCID]
11. Roškar L, Roškar I, Rižner TL, Smrkolj Š. Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer. Biomolecules. 2022;12(1):7. [DOI:10.3390/biom12010007] [PMID] [PMCID]
12. Doldi N, Bassan M, Gulisano M, Broccoli V, Boncinelli E, Ferrari A. Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer. J Gynaecol Endocrinol. 1996;10(6):375-82. [DOI:10.3109/09513599609023600] [PMID]
13. Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer. 1996;78(3):454-60. [DOI:10.1002/(SICI)1097-0142(19960801)78:33.0.CO;2-Y]
14. Ferenczy A. Pathophysiology of endometrial bleeding. Maturitas. 2003;45(1):1-14. [DOI:10.1016/S0378-5122(03)00068-9] [PMID]
15. Lax SF, Kurman RJ, Pizer ES, Wu L, Ronnett BM. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol. 2000;24(9):1201-8. [DOI:10.1097/00000478-200009000-00002] [PMID]
16. Koyuncu K, Altın D, Turgay B, Varlı B, Konuralp B, Şükür YE, et al. Binary grading may be more appropriate for endometrial cancer. J Turk Ger Gynecol Assoc. 2020;21(3):163-70. [DOI:10.4274/jtgga.galenos.2019.2019.0068] [PMID] [PMCID]
17. Vaccarello L, Apte SM, Copeland LJ, Boutselis JG, Rubin SC. Endometrial Carcinoma Associated with Pregnancy: A Report of Three Cases and Review of the Literature. Gynecol Oncol. 1999;74(1):118-22. [DOI:10.1006/gyno.1999.5369] [PMID]